This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nyska, A. Articles by Maronpot, R. R. Search for Related Content PubMed PubMed Citation Articles by Nyska, A. Articles by Maronpot, R. R. Social Bookmarking                         What's this?

New Tools in Therapeutic Research—Prostatic Cancer and Models

National Institute of Environmental Health Sciences (NIEHS), Laboratory of Experimental Pathology, Research Triangle Park, North Carolina 27709, USA, nyska{at}niehs.nih.gov

Anthony Dayan

Retired, London, UK

Robert R. Maronpot

National Institute of Environmental Health Sciences (NIEHS), Laboratory of Experimental Pathology, Research Triangle Park, North Carolina 27709, USA

References

• Allen NE, Appleby PN, Davey GK, Key TJ (2000). Hormones and diet: Low insulin-like growth factor-I but normal bioavailabl e androgen s in vegan men. Br J Cancer 83: 95—97.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Allen NE, Forrest MS, Key TJ (2001). The association between polymorphisms in the CYP17 and 5-alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev 10: 185—189.[Abstract/Free Full Text]
• Bosland MC (1992 ). Animal models for the study of prostate carcinogenesis. J Cell Biochem (Suppl) 16H: 89—98.
• Bosland MC (1999). Use of animal models in defi ning effi cacy of chemoprevention agents against prostate cancer. Eur Urol 35: 459—463.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bosland MC, Ford H., Horton L. (1995). Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague—Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 16: 1311—1317.[Abstract/Free Full Text]
• Bosland MC, Walden PD, Taneja S. (1999). Animal and tissue culture models of prostate cancer. In: Prostate Diseases, Lepor H (ed). WB Saunders, Philadelphia, pp 357—370.
• BostwickDG, Ramnani D., Qian J. ( 2000). Prostatic intraepithelial neoplasia: Animal models. Prostate 43: 286—294.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• BubendorfL, Kononen J., Koivisto P., Schraml P., Moch H., Gassser TC, Willi N., Mihatsch MJ, Sauter G., Kallioniemi OP (1999). Survey of gene amplifi- cations during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59: 803—806.[Abstract/Free Full Text]
• Burgess JK, Hazelton RH (2000). New developments in the analysis of gene expression. Redox Rep 5: 63—73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• DiGiovanni J., Kiguchi K., Frijhoff A., Wilker E., Bol DK, Beltran L., Moats S., Ramirez A., Jorcano J., Conti C. (2000). Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 97: 3455—3460.[Abstract/Free Full Text]
• Eisenberger MA, Simon R., O'Dwyer PJ, Wittes RE, Friedman MA (1985). A reevaluation of non-hormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma. J Clin Oncol 3: 827—841.[Abstract/Free Full Text]
• Feinberg AP (2001). Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 98: 591—596.[Abstract/Free Full Text]
• Foster CS, Bostwick DG, Bonkhoff H., Damber JE, van der Kwast T., Montironi R., Sakr WA ( 2000). Cellular and molecular pathology of prostate cancer precursors. Scand J Urol Nephrol Suppl 205: 19—43.[Medline] [Order article via Infotrieve]
• Foster CS, Ke Y. (1997). Stem cells in prostatic epithelia. Int J Exp Pathol 78: 311—329.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Gingrich JR, Greenberg NM (1996). A transgenic mouse prostate cancer model. Toxicol Pathol 24: 502—504.[Free Full Text]
• Go YM, Patel RP, Maland MC, Park H., Beckman JS, Darley-Usmar VM, Jo H. (1999). Evidence for peroxynitrite as a signaling molecule in fl owdependent activation of c-Jun NH(2)-terminal kinase. Am J Physiol 277 (4 Pt 2): H1647—1653.[Web of Science][Medline] [Order article via Infotrieve]
• Goktas D., Crawford DE (1999). Optimal hormonal therapy for advanced prostate carcinoma. Semin Oncol 26: 162—173.[Web of Science][Medline] [Order article via Infotrieve]
• Han X., Liehr JG, Bosland MC (1995). Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone. Carcinogenesis 16: 951— 954.
• Hegde P., Qi R., Abernathy K., Gay C., Dharap S., Gaspard R., Hughes JE, Snesrud E., Lee N., Quackenbush J. (2000). A concise guide to cDNA microarray analysis. Biotechniques 29: 548—550, 552—554, 556.
• Ho SM, Lee KF, Lane K. ( 1997). Neoplastic transformation of the prostate. In: Prostate: Basic and Clinical Aspect, Naz RK (ed). CRC Press, Boca Raton, FL, pp 74—114.
• Ho SM, Roy D. (1994). Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats. Cancer Lett 84: 155—162.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Johnson P., Ho S., Welby C., Hjelm M., Ho CS, Patel T., Townsend R., Amess B., Moyses C., Parekh R. (1998). Application of Proteome Analysis to the Detection of "Hepatoma-Specific" Serum Proteins. Proceedings of the 89th Annual Meeting of the American Association for Cancer Research, vol 39, New Orleans, LA.
• Jungblut PR, Zimny-Arndt U., Zeindl-Eberhart E., Stulik J., Koupilova K., Pleißner K-P., Otto A., Müller E-C., Sokolowska-Köhler W., Grabher G., Stöffler G. (1999). Proteomics inhuman disease: Cancer, heart and infectious diseases. Electrophoresis 20: 2100—2110.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ke Y., Jing C., Barraclough R., Smith P., Davies MP, Foster CS (1997). Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells. Int J Cancer 71: 832—837.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kennedy S. (2001). Proteomic profi ling from human samples: The body fl uid alternative. Toxicol Lett 120: 379—384.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M., Sauter G., Kallioniemi OP (1998). Tissue microarrays for high-throughput molecular profi ling of tumor specimens. Nat Med 4: 844—847.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Leav I., Ho SM, Ofner P., Merk FB, Kwan PW, Damassa D. (1988). Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 80: 1045—1053.[Abstract/Free Full Text]
• Li X., De Sarno P., Song L., Beckman JS, Jope RS ( 1998). Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: Attenuated effects in human 1321N1 astrocytoma cells. Biochem J 331( Pt 2): 599—606.[Web of Science][Medline] [Order article via Infotrieve]
• Lucia MS, Bostwick DG, Bosland M., Cockett ATK, Knapp DW, Leav I., Pollard M., Rinker-Schaeffer C., Shirai T., Watkins BA (1998). Work group I: Rodent models of prostate cancer. Prostate 36: 49—55.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Moyses C. (1999). Pharmacogenetics, genomics, proteomics: The new frontiers in drug development. Int J Pharm Med 13: 197—202.
• Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002—5011.[Abstract/Free Full Text]
• Page MJ, Amess B., Reid TR, Parekh R., Herath A., Brusten L., Zvelebil MJ, Stein RC, Waterfi eld MD, Davies SC, O'Hare MJ (1999). Proteomic defi nition of normal human luminal and myoepithelial breast cells purifi ed from reduction mammoplasties. Proc Natl Acad Sci USA 96: 12589— 12594.[Abstract/Free Full Text]
• Patel AC, Anna CH ( 2000). Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinoma s and mouse lung cell lines. Carcinogenesis 21: 1691—1700.[Abstract/Free Full Text]
• Ripple G., Wilding G. (1999). Drug development in prostate cancer. Semin Oncol 26: 217—226.[Web of Science][Medline] [Order article via Infotrieve]
• Suwa T., Nyska A., Haseman JK, Mahler JF, Maronpot RR (2001). Background lesions and sectioning of male accessory sex organs in B6C3F1 mouse. Toxicol Pathol 30.
• Suwa T., Nyska A., Peckham JC, Hailey JR, Mahler JF, Haseman JK, Maronpot RR (2001). A retrospective analysis of background lesions and tissue accountability for male accessory sex organs in Fischer-344 rats. Toxicol Pathol 29: 467—478.[Abstract/Free Full Text]
• Tam NN, Chung SS, Lee DT, Wong YC ( 2000). Aberrant expression of hepatocyte growth factor and its receptor, c-met, during sex hormone-induced prostatic carcinogenesis in the Noble rat. Carcinogenesis 21: 2183—2191.[Abstract/Free Full Text]
• Simone NS, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA (1998). Laser-capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet 14: 272—276.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tennant TR, Kim H., Sokoloff M., Rinker-Schaeffer CW (2000). The Dunning model. Prostate 43: 295—302.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• van Weerden MW, Romijn JC (2000). Use of nude mouse xenograft models in prostate cancer research. Prostate 43: 263—271.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vercoutter-Edouart AS, Czeszak X., Crepin M., Lemoine J., Boilly B., Le Bourhis X., Peyrat JP, Hondermarck H. (2001). Proteomic detection of change s in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res 262: 59—68.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wang Y., Hayward SW, Donjacour AA, Young P., Jacks T., Sage J., Dahiya R., Cardiff R., Day ML, Cunha GR (2000). Hormonal carcinogenesis of the Rb-knockout mouse prostate. Cancer Res 69: 6008—6017.

Toxicologic Pathology, Vol. 30, No. 2, 283-287 (2002)
DOI: 10.1080/019262302753559623


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. C.L. Schuh Trials, Tribulations, and Trends in Tumor Modeling in Mice Toxicol Pathol, January 1, 2004; 32(1_suppl): 53 - 66. [Abstract] [PDF]

				R. Kohen and A. Nyska Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification Toxicol Pathol, October 1, 2002; 30(6): 620 - 650. [Abstract] [PDF]

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nyska, A. Articles by Maronpot, R. R. Search for Related Content PubMed PubMed Citation Articles by Nyska, A. Articles by Maronpot, R. R. Social Bookmarking                         What's this?